Legal & General Group’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $488K | Buy |
36,049
+33,467
| +1,296% | +$453K | ﹤0.01% | 2450 |
|
|
2025
Q1 | $41K | Hold |
2,582
| – | – | ﹤0.01% | 2753 |
|
|
2024
Q4 | $31.8K | Hold |
2,582
| – | – | ﹤0.01% | 2869 |
|
|
2024
Q3 | $31.2K | Hold |
2,582
| – | – | ﹤0.01% | 2884 |
|
|
2024
Q2 | $30.2K | Buy |
2,582
+900
| +54% | +$10.5K | ﹤0.01% | 2878 |
|
|
2024
Q1 | $21.7K | Hold |
1,682
| – | – | ﹤0.01% | 2928 |
|
|
2023
Q4 | $14.5K | Buy |
1,682
+489
| +41% | +$4.21K | ﹤0.01% | 3156 |
|
|
2023
Q3 | $11.4K | Sell |
1,193
-251
| -17% | -$2.39K | ﹤0.01% | 3243 |
|
|
2023
Q2 | $24.7K | Buy |
1,444
+171
| +13% | +$2.92K | ﹤0.01% | 3023 |
|
|
2023
Q1 | $19.9K | Buy |
+1,273
| New | +$19.9K | ﹤0.01% | 3069 |
|